(NASDAQ: IRTC) Irhythm Technologies's forecast annual revenue growth rate of 13.64% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.16%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.8%.
Irhythm Technologies's revenue in 2025 is $657,227,000.On average, 5 Wall Street analysts forecast IRTC's revenue for 2025 to be $23,300,852,882, with the lowest IRTC revenue forecast at $23,266,925,965, and the highest IRTC revenue forecast at $23,356,562,423. On average, 5 Wall Street analysts forecast IRTC's revenue for 2026 to be $27,207,203,330, with the lowest IRTC revenue forecast at $27,090,129,762, and the highest IRTC revenue forecast at $27,314,381,547.
In 2027, IRTC is forecast to generate $31,312,810,164 in revenue, with the lowest revenue forecast at $30,900,161,176 and the highest revenue forecast at $31,681,604,755.